All Type of News
Hanmi Pharm’s combination drug ‘Gugu Tams’ enters Samsung Medical Center
‘Gugu Tams,’ a Hanmi Pharm’s benign prostatic hyperplasia and erectile dysfunction treatment, entered Samsung Medical Center.
According to the industry concerned, Hanmi Pharm’s Gugu Tams, Novartis’ Fytarex, Hanlim Ph...
MOHW excluded from ‘Fourth Industrial Revolution Committee,’ while health care industry is mentioned in ‘Special Committee for Health Care’
While the industrial industry, like health care, have a lot of concerns about the Ministry of Health and Welfare being excluded from the ‘Committee for the Fourth Industrial Revolution Innovation,’ all the discussions...
This year, about 40 original medicines expired in patent
Including ‘Viread,’ 40 original medicines owned by multinational pharmaceutical companies with more than KRW 100 billion annual sales will be expired in patent this year.
According to the pharmaceutical industry, sta...
Yuhan Corporation President Jung-Hee Lee is now certain for Chair of the KPBMA
It has become certain about the next Chair of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA), which had brought various rumors.
This is because Yuhan Corporation President Jung-Hee Lee has m...
MFDS’s active plans to mutually approve GMP for medicines with EU countries
The Ministry of Food and Drug Safety’s cooperative project for the mutual GMP(Good Manufacturing Practice) with EU countries has started to produce positive results.
The Ministry of Food and Drug Safety(MFDS) announc...
SK Biopharmaceuticals found joint venture with Glycyx
SK Biopharmaceuticals(CEO Jung-Woo Cho) announced the company founded a joint venture to develop Relenopride as a rare nervous disease treatment with Glycyx Therapeutics Ltd. On the 7th. SK Biopharmaceuticals and Glyc...
Dong Wha Pharm’s plan to recruit officers to target OTC field
Dong Wha Pharm has shown a movement towards the OTC field which the company has remained strong so far. Particularly, it was interesting because the management is related to this OTC-related phenomenon.
A part relate...
Pharmaceutical & biologic manufacturing and industrial engineers excluded from original license plan
Licenses for the biotech and pharmaceutical fields, which had caused issues for the past 3 months, was removed from the ‘Technical License Plan for the Fourth Industrial Revolution’ as accepting opinions from governm...
No.1 for Meng-Ho Lim and No.2 for Sun-Hye Cho at KPDA Presidency
Candidate numbers for the 35th Korea Pharmaceutical Distribution Association(KPDA) Presidential Election are now set.
Candidate Meng-Ho Lim(68) and Candidate Sun-Hye Cho(63) acquired No.1 and No.2 respectively. The t...
14 professional managers at listed pharmas, like Yuhan Corporation CEO Jung-Hee Lee, meet end in term of office this year
14 professional managers in the pharmaceutical industry, like CEO Jung-Hee Lee at Yuhan Corporation and CEO Jong-Wook Lee at Daewoong Pharmaceutical, will meet the end in their term of office and most of the terms wil...
